XJPX4885
Market cap18mUSD
Dec 24, Last price
792.00JPY
1D
1.54%
1Q
5.18%
IPO
-41.89%
Name
Muromachi Chemicals Inc
Chart & Performance
P/E
9.01
P/S
0.47
EPS
87.91
Div Yield, %
2.50%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
6.37b
+1.24%
Net income
330m
+28.83%
CFO
638m
+101.05%
Dividend
May 30, 202422 JPY/sh
Earnings
Jan 14, 2025
Profile
Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals and health foods in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services for radioactive and stable isotope tagged compounds used in pharmaceutical and agricultural metabolic testing, as well as imports and sells active pharmaceutical ingredients. The company also provides jelly and non-alcoholic beverage products. In addition, it offers ion-exchange resins, separation membranes, and ion-exchange fibers; and solutions that meet customers' needs with water-treatment products, including filter media, equipment, and chemicals, as well as commissioned chemical processing services. Further, the company provides functional adhesives; and product contamination removal and dust removal mats, and antistatic products for use in the electronics industry, as well as engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | |
| Income | |||||
Revenues | 6,369,097 1.24% | 6,291,378 10.74% | 5,681,098 14.93% | ||
Cost of revenue | 4,581,461 | 4,572,392 | 3,977,320 | ||
Unusual Expense (Income) | |||||
NOPBT | 1,787,636 | 1,718,986 | 1,703,778 | ||
NOPBT Margin | 28.07% | 27.32% | 29.99% | ||
Operating Taxes | 138,388 | 94,597 | (30,668) | ||
Tax Rate | 7.74% | 5.50% | |||
NOPAT | 1,649,248 | 1,624,389 | 1,734,446 | ||
Net income | 330,197 28.83% | 256,302 -43.83% | 456,272 152.48% | ||
Dividends | (74,488) | (70,615) | (54,845) | ||
Dividend yield | 2.72% | 2.35% | 1.60% | ||
Proceeds from repurchase of equity | 2,210 | 16,543 | (74,859) | ||
BB yield | -0.08% | -0.55% | 2.19% | ||
| Debt | |||||
Debt current | 334,876 | 696,718 | 903,318 | ||
Long-term debt | 1,107,824 | 874,434 | 786,990 | ||
Deferred revenue | (8,734) | (5,108) | |||
Other long-term liabilities | 92,475 | 104,652 | 107,024 | ||
Net debt | 114,810 | 581,993 | 760,339 | ||
| Cash flow | |||||
Cash from operating activities | 637,701 | 317,189 | 524,905 | ||
CAPEX | (239,174) | (110,276) | (170,332) | ||
Cash from investing activities | (232,230) | (162,408) | (176,280) | ||
Cash from financing activities | (209,954) | (172,390) | (483,635) | ||
FCF | 1,626,463 | 1,557,214 | 1,786,377 | ||
| Balance | |||||
Cash | 1,050,427 | 852,606 | 865,361 | ||
Long term investments | 277,463 | 136,553 | 64,608 | ||
Excess cash | 1,009,435 | 674,590 | 645,914 | ||
Stockholders' equity | 1,720,153 | 1,395,554 | 1,201,348 | ||
Invested Capital | 2,791,787 | 2,865,642 | 2,799,333 | ||
ROIC | 58.30% | 57.35% | 62.32% | ||
ROCE | 47.03% | 48.44% | 49.38% | ||
| EV | |||||
Common stock shares outstanding | 4,034 | 3,997 | 4,054 | ||
Price | 678.00 -9.96% | 753.00 -10.68% | 843.00 -32.29% | ||
Market cap | 2,734,904 -9.14% | 3,009,910 -11.92% | 3,417,176 -13.47% | ||
EV | 2,849,714 | 3,591,903 | 4,177,515 | ||
EBITDA | 1,923,823 | 1,841,250 | 1,805,011 | ||
EV/EBITDA | 1.48 | 1.95 | 2.31 | ||
Interest | 18,462 | 17,690 | 17,007 | ||
Interest/NOPBT | 1.03% | 1.03% | 1.00% | ||